Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

Clinical trial NCT07183878 · RECRUITING

Trial details

NCT number: NCT07183878
Sponsor: First Affiliated Hospital of Zhejiang University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Myeloid Leukemia High-Risk Acute Myeloid Leukemia Myelodysplastic Syndromes High-Risk Myelodysplastic Syndromes

Start date: 2025-08-20
Primary completion: 2027-08-20
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.